Nectar Lifesciences Board to consider final dividend

06 May 2013 Evaluate

Nectar Lifesciences has informed that a meeting of the Board of Directors of the Company will be held on May 15, 2013, to consider and approve the following: The Audited Financial Results for Financial Year 2012-13, Balance Sheet of the Company as at March 31, 2013 and Profit A Loss Accounts for the financial year ended on March 31, 2013 and matters related thereto, and recommendation of final dividend to the Members of the Company for Financial Year 2012-13.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

37.76 0.74 (2.00%)
14-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1768.75
Dr. Reddys Lab 1337.30
Cipla 1448.00
Lupin 2155.25
Zydus Lifesciences 1000.80
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.